Correlation Between MoonLake Immunotherapeuti and Innovator IBD
Can any of the company-specific risk be diversified away by investing in both MoonLake Immunotherapeuti and Innovator IBD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MoonLake Immunotherapeuti and Innovator IBD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MoonLake Immunotherapeutics and Innovator IBD 50, you can compare the effects of market volatilities on MoonLake Immunotherapeuti and Innovator IBD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MoonLake Immunotherapeuti with a short position of Innovator IBD. Check out your portfolio center. Please also check ongoing floating volatility patterns of MoonLake Immunotherapeuti and Innovator IBD.
Diversification Opportunities for MoonLake Immunotherapeuti and Innovator IBD
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between MoonLake and Innovator is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding MoonLake Immunotherapeutics and Innovator IBD 50 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator IBD 50 and MoonLake Immunotherapeuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MoonLake Immunotherapeutics are associated (or correlated) with Innovator IBD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator IBD 50 has no effect on the direction of MoonLake Immunotherapeuti i.e., MoonLake Immunotherapeuti and Innovator IBD go up and down completely randomly.
Pair Corralation between MoonLake Immunotherapeuti and Innovator IBD
Given the investment horizon of 90 days MoonLake Immunotherapeuti is expected to generate 1.03 times less return on investment than Innovator IBD. In addition to that, MoonLake Immunotherapeuti is 1.5 times more volatile than Innovator IBD 50. It trades about 0.18 of its total potential returns per unit of risk. Innovator IBD 50 is currently generating about 0.27 per unit of volatility. If you would invest 2,761 in Innovator IBD 50 on August 30, 2024 and sell it today you would earn a total of 362.00 from holding Innovator IBD 50 or generate 13.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
MoonLake Immunotherapeutics vs. Innovator IBD 50
Performance |
| Timeline |
| MoonLake Immunotherapeuti |
| Innovator IBD 50 |
MoonLake Immunotherapeuti and Innovator IBD Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MoonLake Immunotherapeuti and Innovator IBD
The main advantage of trading using opposite MoonLake Immunotherapeuti and Innovator IBD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MoonLake Immunotherapeuti position performs unexpectedly, Innovator IBD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator IBD will offset losses from the drop in Innovator IBD's long position.The idea behind MoonLake Immunotherapeutics and Innovator IBD 50 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Innovator IBD vs. Innovator ETFs Trust | Innovator IBD vs. iShares Expanded Tech Software | Innovator IBD vs. iShares MSCI USA | Innovator IBD vs. Renaissance IPO ETF |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |